Vitreous humor of the human eye is a vital component that acts as nutrition and refractive medium. The vitreous humor is initially a highly viscous gel like substance made up of collagen fibers and water. In case of trauma or upon aging, the vitreous humor disintegrates and in the process ends up tearing or detachment of highly fragile retina. Thus, these retinal detachment and vitreoretinal disorders often require an ophthalmic surgical procedure known as vitrectomy. Vitrectomy procedure involves surgical removal of the vitreous humor that is replaced with synthetic substitute known as vitreous tamponade. These vitreous tamponades act as a retinal reattachment medium thereby aiding the healing process.

Obtain the Future Market Trends of Vitreous Tamponades at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4233

Based on the important information provided in the report regarding the challenges that new entrants face, the strategies used by leading companies in the vitreous tamponades market, and also the present and future trends, an interested individual or enterprise can effectively make smart decisions regarding investment in the market.

Vitreous tamponades are used in vitrectomy procedures conducted in the human eye. These procedures assist in healing or reattachment of the retina and are also used to provide a replacement to a clouded vitreous humor. The vitreous humor of the eye acts as a refractive medium and provides nutrition to the eye. After a trauma or due to the natural process of ageing, the vitreous humor, which is a highly viscous gel-like substance made from collagen and water, starts tearing or getting detached from the fragile retina. To repair this retinal detachment and also for any other vitreoretinal disorders, vitrectomy is required. Vitrectomy involves the removal of the vitreous humor and replacing it with a synthetic substitute. This synthetic substitute is called a vitreous tamponade. Currently, the most commonly used substitutes are: silicone oil, perfluorocarbon liquids, and intraocular gases.

The global vitreous tamponade market is expected to expand due to the rising incidence of retinal detachment and growth of the geriatric population. The growing cases of diabetic retinopathy, macular pucker, and similar other retinal disorders are also driving the global vitreous tamponade market. Vitreous substitutes are biocompatible and transparent, which allow them to replace natural vitreous humor successfully.

The global vitreous tamponade market is segmented on the basis of type and geography. On the basis of type, the market is segmented into gaseous tamponades and liquid tamponades. Liquid tamponades are further classified into silicone oil and perfluorocarbons. Although the liquid tamponades market was the leading segment in 2013, accounting for 49% of the global market, the gaseous tamponades segment is expected to grow at a faster rate due to their ease of use and lower costs. The most extensively used gaseous tamponades in vitreoretinal surgeries are C2F8, SF6, and C3F8, as these gases are expansive and allow the eyeball and the retina to gradually adjust to the volume of the eye, enabling better healing.

Read the Current Market Analysis of Vitreous Tamponades at: http://www.transparencymarketresearch.com/vitreous-tamponades-market.html

Some of the key manufacturers of vitreous tamponades profiled in the report are: Valeant Pharmaceuticals International, Inc. (parent of Bausch + Lomb), Alcon, Inc., Carl Zeiss Meditec AG, Fluoron GmbH, Dutch Ophthalmic Research Center B.V., AL.CHI.MI.A Srl, and Croma Pharma AG.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com/